Multidisciplinary strategies for the management of heart failure patients at high risk for admission A systematic review of randomized trials by McAlister, Finlay A. et al.
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OBJECTIVES The aim of this study was to determine whether multidisciplinary strategies improve
outcomes for heart failure (HF) patients.
BACKGROUND Because the prognosis of HF remains poor despite pharmacotherapy, there is increasing
interest in alternative models of care delivery for these patients.
METHODS Randomized trials of multidisciplinary management programs in HF were identified by
searching electronic databases and bibliographies and via contact with experts.
RESULTS Twenty-nine trials (5,039 patients) were identified but were not pooled, because of considerable
heterogeneity. A priori, we divided the interventions into homogeneous groups that were suitable
for pooling. Strategies that incorporated follow-up by a specialized multidisciplinary team (either
in a clinic or a non-clinic setting) reduced mortality (risk ratio [RR] 0.75, 95% confidence interval
[CI] 0.59 to 0.96), HF hospitalizations (RR 0.74, 95% CI 0.63 to 0.87), and all-cause
hospitalizations (RR 0.81, 95% CI 0.71 to 0.92). Programs that focused on enhancing patient
self-care activities reduced HF hospitalizations (RR 0.66, 95% CI 0.52 to 0.83) and all-cause
hospitalizations (RR 0.73, 95% CI 0.57 to 0.93) but had no effect on mortality (RR 1.14, 95% CI
0.67 to 1.94). Strategies that employed telephone contact and advised patients to attend their
primary care physician in the event of deterioration reduced HF hospitalizations (RR 0.75, 95%
CI 0.57 to 0.99) but not mortality (RR 0.91, 95% CI 0.67 to 1.29) or all-cause hospitalizations
(RR 0.98, 95% CI 0.80 to 1.20). In 15 of 18 trials that evaluated cost, multidisciplinary strategies
were cost-saving.
CONCLUSIONS Multidisciplinary strategies for the management of patients with HF reduce HF hospital-
izations. Those programs that involve specialized follow-up by a multidisciplinary team also
reduce mortality and all-cause hospitalizations. (J Am Coll Cardiol 2004;44:810–9) © 2004
by the American College of Cardiology Foundatione
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meart failure (HF) is the most common discharge diagnosis
n elderly patients, accounts for almost a quarter of all
ardiovascular hospitalizations, and consumes 1% to 2% of
otal health care expenditures (1). Although a number of
harmacologic treatments have been shown to improve
utcomes in patients with HF (2), the prognosis of these
atients remains poor (3). Thus, there is a need for other
pproaches to management. Although the vast majority of
F research has focused on drug or electrical therapies,
rograms involving multidisciplinary teams are increasingly
outed as a potential strategy for further improving out-
omes in HF patients (2). Although some of the purported
mprovements may arise from better application of the
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Manuscript received January 20, 2004; revised manuscript received April 8, 2004,mccepted May 11, 2004.vidence into practice, these multidisciplinary strategies may
lso better address the complex interplay between medical,
sychosocial, and behavioral factors facing patients with HF
nd their caregivers.
Most initial studies of multidisciplinary interventions
ere non-randomized, “before and after” case series, raising
oncerns about their interpretation (4). However, in an
arlier systematic review restricted to the 11 randomized
rials published up until 1999, we demonstrated that man-
gement strategies for patients with HF that involved
pecialized follow-up by a multidisciplinary team reduced
ospitalizations and appeared to be cost-saving (5). These
onclusions were reinforced in a recently published system-
tic review incorporating another seven trials (for a total of
8 trials) (6). However, their effectiveness in improving
ther clinical outcomes (particularly mortality) was indeter-
inate in both earlier reviews owing to limited numbers of
vents. Importantly, the number of studies was also insuf-
cient to allow comparison of the relative benefits of the
ifferent types of interventions. In the past five years, several
ore trials of multidisciplinary strategies for the manage-
ent of HF have been published.
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August 18, 2004:810–9 Multidisciplinary Management of HFThus, we updated our earlier systematic review to incor-
orate this new evidence and to investigate which types of
rograms are most efficacious.
ETHODS
dentifying relevant studies. We searched for randomized
rials in Medline 1966 to 2003, Embase 1980 to 2003,
inahl 1982 to 2003, Sigle 1980 to 2003, AMED (Allied
nd Complementary Medicine) 1985 to 2003, the Cochrane
ontrolled Trial Registry, and the Cochrane Effective
ractice and Organization of Care Study Registry. Lan-
uage restrictions were not applied. The following textword
erms and medical subject headings were used: “case man-
gement (exp), comprehensive health care (exp), disease
anagement (exp), health services research (exp), home care
ervices (exp), clinical protocols (exp), patient care planning
exp), quality of health care (exp), nurse led clinics, special
linics” and “heart failure, congestive (exp).” Bibliographies
f identified studies were hand-searched. We also contacted
ontent experts and authors of the primary studies to
dentify any studies missed by the electronic searches.
tudy selection and data abstraction. F.M. and J.M.
ndependently reviewed the results of the search strategy
nd selected all studies reporting the impact of outpatient-
ased multidisciplinary management strategies on mortality
r hospitalization rates in patients with HF. Studies were
xcluded if they: appeared in abstract form only, did not
eport either of the outcomes of interest, employed inpatient
nterventions only, did not utilize a multidisciplinary ap-
roach, or if they enrolled patients with multiple diseases
nd data for patients with HF were not reported separately
r could not be determined after contact with the authors.
F.M. and S.S. independently assigned each reported
ntervention to one of four a priori defined groups: 1) a.
ultidisciplinary HF clinic; b. multidisciplinary team pro-
iding specialized follow-up but not in a hospital or
ractice-based clinic; 2) telephone follow-up or telemoni-
oring and enhanced communication with primary care
hysician (including advice to deteriorating patients to see
heir regular physician); or 3) educational programs de-
igned to enhance patient self-care activities. It should be
oted that patient education was a key component of all four
ypes of interventions (Table 1). These groupings were
eviewed and approved at an ad hoc meeting of HF disease
anagement investigators, including six of the authors of
rimary studies included in our systematic review (personal
Abbreviations and Acronyms
CI  confidence interval
HF  heart failure
NNT  number needed to treat
RR  risk ratioommunication, Simon Stewart, February 26, 2004). All vutcome data were extracted by F.M. and J.M. indepen-
ently.
Outcomes from each study were assigned according to
he intention-to-treat principle, and we accepted the defi-
itions for each outcome used by the investigators in the
rimary studies. Original investigators were contacted to
larify the published data: authors for 14 of the 20 studies
ontacted provided further data. We defined “all-cause
ospitalization rate” and “heart failure hospitalization rate”
s the number of patients in each trial arm who were
ospitalized at least once (thus, each patient could only
ontribute one event to these analyses). We defined “total
ospitalizations” and “total heart failure hospitalizations” as
he total number of hospitalizations in each trial arm—thus,
hese end points incorporate multiple re-admissions from
he same patient.
tatistical analysis. Analyses were performed using the
eta-Analyst 0.998 software (J. Lau, New England Med-
cal Center, Boston, Massachusetts). As the outcomes of
nterest were relatively common, we calculated risk ratios.
ntention-to-treat analyses were done, and the DerSimo-
ian and Laird random effects model was employed for all
nalyses. Because of the differences expected between stud-
es (particularly in the usual care arms), a priori we decided
o examine for statistical heterogeneity using Cochran’s Q
est. If the heterogeneity p value was 0.20, we elected not
o pool the data but to examine outcomes in the a priori
efined intervention groups separately (but only if there was
o substantial heterogeneity within the subgroups). Sensi-
ivity analyses, defined a priori, were conducted to look at
he effects of duration of intervention, quality of trial (using
he Jadad scale) (7), length of follow-up, and year of study
ompletion on the summary risk ratios. We calculated
djusted indirect comparisons to compare different types of
nterventions according to the method of Song et al. (8).
ESULTS
tudy selection and evaluation. Of the 853 citations
dentified in our search, 76 were eligible for inclusion in this
ystematic review (Fig. 1, QUOROM flow chart). How-
ver, 38 of these studies were excluded as follows: 21 were
ot randomized, 5 did not report the underlying diagnoses
n the enrolled patients (and such data could not be obtained
ven after contacting authors), 4 did not include the
utcomes of interest, 2 evaluated telephone follow-up in lieu
f clinic visits rather than a multidisciplinary strategy, 2 did
ot include a “usual care” control arm, 2 were protocols for
ngoing trials, 1 tested an inpatient-based intervention only,
nd 1 tested patient self-management alone. Of the 29
andomized trials included in this systematic review, 7
eported results in more than one publication (only the main
ublication from each trial is referenced here) (9–15).
Disagreement among the two reviewers regarding eligi-
ility of the studies occurred on seven occasions for a kappa
alue of 0.77, and disagreement on type of intervention
Table 1. Description of Studies Included
Study (Year) (Ref.) Sample Size Study Population (Location)
Mean
Age Key Components of Intervention
Duration of
Intervention
Multidisciplinary heart failure clinic
Cline et al. (1998) (16) 190 Patients 65–84 yrs with heart failure discharged
from hospital (Sweden)
76 Nurse-led patient education, self-management
guidelines for patients, and follow-up visits
at nurse-run clinic as needed after
discharge
12 mos
Ekman et al. (1998) (17) 158 Patients with moderate-severe heart failure
discharged from hospital (Sweden)
80 Nurse-led patient education, self-management
guidelines for patients, follow-up visits at
nurse-run clinic as needed, frequent
telephone follow-up
6 mos
Doughty et al. (2002) (14) 197 Patients with heart failure discharged from
hospital (New Zealand)
73 Multidisciplinary heart failure clinic with
regularly scheduled follow-up, patient
education sessions, close liaison with
primary care physician
12 mos
Kasper et al. (2002) (18) 200 Patients with heart failure discharged from
hospital and having at least one risk factor
for readmission (U.S.)
62 Multidisciplinary heart failure clinic (mean 8
visits), primarily nurse-led, with protocol-
driven patient assessments and medication
adjustments, regular telephone contact
(mean 10 calls)
6 mos
Capomolla et al. (2002) (19) 234 Patients discharged from a heart failure unit
(Italy)
56 Multidisciplinary heart failure clinic with
regularly scheduled telephone contact
12 mos
Stromberg et al. (2003) (20) 106 Patients with heart failure discharged from
hospital (Sweden)
78 Nurse-led heart failure clinic, protocol-driven
changes in medications, patient education,
psychosocial support
12 mos
Ledwidge et al. (2003) (13) 98 Patients with heart failure discharged from
hospital (Ireland)
71 Multidisciplinary heart failure clinic with
regularly scheduled telephone contact
(11 calls)
3 mos
Multidisciplinary team providing specialized
follow-up in non-clinic setting
Hanchett and Torrens (1967) (21) 239 Patients with heart failure attending specialty
clinic (U.S.)
60–69
median
Nurse-led patient education, regular telephone
contact, regular home/clinic visits
30 mos
Rich et al. (1993) (22) 98 Patients 70 yrs with heart failure discharged
from hospital and having clinical features
suggesting they were at moderate or high
risk for readmission (U.S.)
79 Nurse-led patient education, dietary and
social services consultation, review of
medications by geriatric cardiologist, and
intensive follow-up at home by study team
3 mos
Rich et al. (1995) (9) 282 Patients 70 yrs with heart failure discharged
from hospital and having clinical features
suggesting they were at high risk for
readmission (U.S.)
79 Nurse-led patient education, dietary and
social services consultation, review of
medications by geriatric cardiologist, and
intensive follow-up at home by study team
3 mos
Stewart et al. (1998) (11) 97 Patients with heart failure discharged from
hospital with clinical features suggesting they
were at high risk for readmission (Australia)
75 Nurse-led patient education, home visit by
nurse and pharmacist 7 days after discharge
to optimize medications and detect early
clinical deterioration; compliance aids given
to “at risk” patients
One visit
Continued on next page
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Table 1 Continued
Study (Year) (Ref.) Sample Size Study Population (Location)
Mean
Age Key Components of Intervention
Duration of
Intervention
Stewart et al. (1999) (25) 200 Patients 55 years with heart failure
discharged from hospital (Australia)
76 Nurse-led patient education, counselling,
exercise regimen, home visit 7–14 days
after discharge and assessment re need for
medication adjustments as per protocol,
and telephone contact at 3 mos and 6 mos
6 mos
Naylor et al. (1999) (12) 363 (108 with heart
failure)
Patients 65 years discharged from a tertiary
care hospital with either coronary disease or
heart failure (U.S.)
75 Nurse-led patient education, coordination of
home care, at least two home visits, use of a
standardized protocol to optimize
medications, and weekly telephone contact
for 1 month
1 mo
Blue et al. (2001) (27) 165 Patients with heart failure discharged from
hospital (U.K.)
75 Nurse-led patient education, initial visit in
hospital, home visits and telephone contact
as needed, psychological support, protocol-
driven titration of medications, liaison with
other health care workers
12 mos
Trochu et al. (2004) (37) 202 Patients 65 years or older with heart failure
discharged from hospital for a second time
(France)
77 Nurse-led patient education, initial visit in
hospital, home visit 2 weeks after discharge
and monthly telephone contact,
psychological support, liaison with other
health care workers
12 mos
Telephone follow-up and attendance with
primary care physician if deteriorates
Naylor et al. (1994) (28) 276 (142 with
coronary disease
or heart failure)
Patients 70 yrs discharged from a tertiary
care hospital with either coronary disease or
heart failure (U.S.)
76 Comprehensive discharge planning protocol
with gerontologic nurse providing
education, coordinating care, and
maintaining telephone contact for 2 weeks
(with modification of treatment plan if
appropriate)
0.5 mo
Weinberger et al. (1996) (10) 1,396 (504 with
heart failure)
Patients discharged from the general medicine
service with heart failure, diabetes mellitus,
or chronic obstructive pulmonary disease
(U.S.)
63 Primary care nurse provided educational
materials and coordinated care between
discharge and outpatient clinics, regular
telephone follow-up through the course of
the study, primary care physician follow-up
within 7 days of discharge
6 mos
PHARM (1999) (29) 181 Patients with heart failure being evaluated in
cardiology clinic (U.S.)
67 Clinical pharmacist-led medication review,
patient education, regularly scheduled
telephone contact  3 to detect clinical
deterioration early
6 mos
Rainville (1999) (30) 34 Patients 50 years discharged from hospital
with heart failure (U.S.)
70 Pharmacist-led medication review, patient
education, telephone contact  2
0.25 mo
Continued on next page
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Table 1 Continued
Study (Year) (Ref.) Sample Size Study Population (Location)
Mean
Age Key Components of Intervention
Duration of
Intervention
Pugh et al. (2001) (26) 58 Patients 65 years discharged from hospital
with heart failure (U.S.)
77 Nurse-led patient education, regular follow-up
via telephone and clinic visits with nurse
manager
6 mos
Jerant et al. (2001) (15) 37 Patients 40 years discharged from hospital
with heart failure (U.S.)
70 Nurse contact via telephone (mean 6 calls) or
video-based home telecare (mean 9 calls),
patient education, protocol-driven review of
symptoms, medication compliance, and
medication dosing, with communication to
primary care physician if deterioration
2 mos
de Lusignan et al. (2001) (31) 20 Adult patients with heart failure confirmed by
cardiologist, identified from the database of
an academic general practice (U.K.)
75 Telemonitoring of vital signs and clinical
status daily, video consult with study nurse
weekly  3 mos, bi-weekly  3 mos, then
monthly
12 mos
Riegel et al. (2002) (33) 358 Patients discharged from hospital with heart
failure (U.S.)
74 Nurse telephone contact (median 14 calls),
patient education and counseling, case
management guided by computer decision
support, liaison with primary care
physicians
6 mos
Laramee et al. (2003) (35) 287 Patients discharged from hospital with heart
failure and having at least one risk factor for
readmission (U.S.)
71 Early discharge planning, patient education,
regularly scheduled telephone contact
(12 weeks, 9 calls), case manager sent
reminders to primary care physician if not
on target medications
3 mos
Tsuyuki et al. (2004) (36) 276 Patients discharged from hospital with heart
failure (Canada)
72 Early discharge planning with provision of
adherence aids, patient education, regularly
scheduled telephone contact (24 weeks,
7 calls) with recommendation to see
primary care physician if not on target dose
ACE inhibitor or deteriorated
6 mos
Enhanced patient self-care activities
Serxner et al. (1998) (23) 109 Patients discharged from hospital with
diagnosis of heart failure (U.S.)
71 Mailed patient education materials to
encourage self-management
3 mos
Jaarsma et al. (1999) (24) 179 Patients 50 years with heart failure
discharged from hospital (Netherlands)
73 Nurse-led patient education, home visit after
discharge to reinforce education and self-
care plan
0.25 mo
Krumholz et al. (2002) (34) 88 Patients 50 years discharged from hospital
with heart failure (U.S.)
74 Nurse-led patient education, regular telephone
contact to monitor for deterioration
(17 calls) but no modifications of treatment
by nurse educator
12 mos
Harrison et al. (2002) (32) 192 Patients discharged from hospital with heart
failure (Canada)
76 Patient education and counseling, education
booklet and map used at home
0.5 mos
ACE  angiotensin-converting enzyme; PHARM  Pharmacist in Heart failure Assessment Recommendation and Monitoring study.
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August 18, 2004:810–9 Multidisciplinary Management of HFccurred on four occasions for a kappa value of 0.86. All
isagreements were resolved by consensus.
tudies included in the systematic review. Summary data
rom the 29 randomized trials are presented in Table 1
9–37). In all trials, the control groups received usual care
which was generally ill-defined).
uantitative data synthesis. ALL-CAUSE MORTALITY. Two
f the 22 trials reporting mortality end points found a
ignificant difference between the intervention and control
atients during the pre-specified study periods (Table 2); a
hird group of investigators (11) subsequently reported a
ignificant difference after 18 months of follow-up (2 deaths
n the intervention arm and 9 in the control arm, p  0.02)
38). The summary risk ratio (RR) for all 22 trials (3,781
atients) was 0.83 (95% confidence interval [CI] 0.70 to
.99); however, although heterogeneity testing was not
ignificant (p  0.15), there was a strong enough trend that
e thought the data should not be pooled across all trials.
ather, we examined results within the a priori defined
ntervention subgroups. Multidisciplinary teams providing
pecialized follow-up were associated with significant reduc-
ions in mortality (RR 0.75 [95% CI 0.59 to 0.96], number
eeded to treat [NNT] 17), with similar results whether
hat follow-up was done in HF clinics (RR 0.66, 95% CI
.42 to 1.05) or not (RR 0.81, 95% CI 0.65 to 1.01). On the
ther hand, no mortality reductions were seen with those
trategies that were based on telephone follow-up with
nstructions to see regular physician if deteriorating (RR
.91, 95% CI 0.65 to 1.29) or those programs that empha-
ized enhanced patient self-care activities (RR 1.14, 95% CI
.67 to 1.94). The adjusted indirect comparison (8) con-
rmed that mortality reductions were greater with multi-
isciplinary teams providing specialized follow-up (whether
n HF clinics or non-clinic settings) than programs that
elied on enhanced self-care activities alone (adjusted RR
.66, 95% CI 0.46 to 0.94) or programs that employed
egular telephone contact and follow-up with primary care
igure 1. Flow diagram of study selection. RCT  randomized controlled
rial.ractitioners (adjusted RR 0.82, 95% CI 0.54 to 1.25). (LL-CAUSE HOSPITALIZATION RATE. Whereas three trials
eported a statistically significant reduction in hospitaliza-
ions for any reason in patients randomized to the multi-
isciplinary management strategies, 18 failed to detect any
ignificant difference and 1 reported excess hospitalization
ates in the intervention arm (Table 2). Although for the 23
rials (4,313 patients) the summary risk ratio of 0.84 (95%
I 0.75 to 0.93) is consistent with a beneficial impact from
he interventions, there was significant heterogeneity in the
esults (p  0.01).
This statistical heterogeneity again highlights the differ-
nces between the intervention categories noted earlier.
hose trials evaluating the impact of frequent telephone
ontact with advice to those patients exhibiting deteriora-
ion to see their regular physician demonstrated no impact
n all-cause hospitalization rates (RR 0.98, 95% CI 0.80 to
.20). This is in contradistinction to trials evaluating mul-
idisciplinary teams providing specialized follow-up
RR 0.81 [95% CI 0.71 to 0.92] and NNT 10, with similar
esults for follow-up in clinic (RR 0.76, 95% CI 0.58 to
.01) or non-clinic (RR 0.81, 95% CI 0.72 to 0.91) settings,
r programs that emphasized enhanced patient self-care
ctivities (RR 0.73, 95% CI 0.57 to 0.93). The adjusted
ndirect comparison (8) confirmed that, compared with
rograms that employed regular telephone contact and
ollow-up with primary care practitioners, all-cause hospi-
alizations were affected more by programs that emphasized
nhanced patient self-care activities (adjusted RR 0.75, 95%
I 0.63 to 0.88) or multidisciplinary teams providing
pecialized follow-up (adjusted RR 0.81, 95% CI 0.63 to
.04) compared with telephone contact and follow-up with
rimary care physician.
F HOSPITALIZATION RATE. Six of the 19 trials reporting
his end point found statistically significant reductions in
he need for at least one HF hospitalization with multidis-
iplinary management strategies, and the pooled effect
stimate suggested a substantial impact (RR 0.73, 95% CI
.66 to 0.82, p  0.36 for heterogeneity, NNT  11 to
revent 1 patient from being hospitalized for HF) on this
utcome (Table 2). Results were similar for specialized
ollow-up by a multidisciplinary team (RR 0.74, 95% CI
.63 to 0.87) either in an HF clinic (RR 0.76, 95% CI 0.58
o 0.099) or in a non-clinic setting (RR 0.72, 95% CI 0.59
o 0.87), programs employing telephone follow-up (RR
.75, 95% CI 0.57 to 0.99), or programs emphasizing
nhanced patient self-care activities (RR 0.66, 95% CI 0.52
o 0.83). Given the similarity in the summary estimates,
djusted indirect comparisons were not performed.
OTAL NUMBER OF HOSPITALIZATIONS. Twenty-one trials
eported total number of hospitalizations by treatment arm;
n 11 of these trials, the intervention arm had significantly
ewer total hospitalizations. Pooling the data from all 21
rials revealed a marked reduction in total number of
ospitalizations (RR 0.70, 95% CI 0.62 to 0.80), with no
ppreciable differences between multidisciplinary HF clinics
RR 0.61, 95% CI 0.39 to 0.94), specialized follow-up by
Table 2. Impact of Interventions on All-Cause Mortality, All-Cause Hospitalization Rates, and Heart Failure Hospitalization Rates
Study (Year) (Ref.)
Length of
Follow-Up
(mos)
All-Cause Mortality (# Events/Total # Pts)
All-Cause Hospitalization Rates
(# Re-Admitted at Least Once/
Total # Patients)*
Heart Failure Hospitalization Rates
(# Re-Admitted at Least Once/
Total # Patients)*
Intervention
Arm
Control
Arm
Risk Ratio
(95% CI)
Intervention
Arm
Control
Arm
Risk Ratio
(95% CI)
Intervention
Arm
Control
Arm
Risk Ratio
(95% CI)
Multidisciplinary heart failure
clinic
Cline et al. (1998) (16)† 12 24/80 31/110 1.06 (0.68, 1.67) 22/56 43/79 0.72 (0.49, 1.06) NR NR NR
Ekman et al. (1998) (17) 6 21/79 17/79 1.24 (0.71, 2.16) 48/79 45/79 1.07 (0.82, 1.38) 36/79 38/79 0.95 (0.68, 1.32)
Doughty et al. (2002) (14) 12 19/100 24/97 0.77 (0.45, 1.31) 64/100 59/97 1.05 (0.85, 1.31) 21/100 23/97 0.89 (0.53, 1.49)
Kasper et al. (2002) (18) 6 7/102 13/98 0.52 (0.22, 1.24) 40/102 42/98 0.92 (0.66, 1.28) 26/102 35/98 0.71 (0.47, 1.09)
Capomolla et al. (2002) (19) 12 3/112 21/122 0.16 (0.05, 0.51) 9/112 37/122 0.26 (0.13, 0.52) NR NR NR
Stromberg et al. (2003) (20)* 12 7/52 20/54 0.36 (0.17, 0.79) 28/52 37/54 0.79 (0.58, 1.07) 17/52 27/54 0.65 (0.41, 1.05)
Ledwidge et al. (2003) (13) 3 3/51 3/47 0.92 (0.20, 4.34) 2/51 12/47 0.15 (0.04, 0.65) 2/51 10/47 0.18 (0.04, 0.80)
Subtotal 0.66 (0.42, 1.05) 0.76 (0.58, 1.01) 0.76 (0.58, 0.99)
Multidisciplinary team providing
specialized follow-up in non-
clinic setting
Hanchett and Torrens (1967) (21)‡ 30 NR NR NR NR NR NR NR NR NR
Rich et al. (1993) (22) 3 NR NR NR 21/63 16/35 0.73 (0.44, 1.20) NR NR NR
Rich et al. (1995) (9) 3 13/142 17/140 0.75 (0.38, 1.49) 41/142 59/140 0.69 (0.50, 0.95) NR NR NR
Stewart et al. (1948) (11)* 6 6/49 12/48 0.49 (0.20, 1.20) 24/49 31/48 0.76 (0.53, 1.08) 12/49 18/48 0.65 (0.35, 1.20)
Stewart et al. (1999) (25)* 6 18/100 28/100 0.64 (0.38, 1.08) 40/100 51/100 0.78 (0.58, 1.07) 21/100 27/100 0.78 (0.47, 1.28)
Naylor et al. (1999) (12)* 6 NR NR NR 18/52 26/56 0.75 (0.47, 1.19) NR NR NR
Blue et al. (2001) (27) 12 25/84 25/81 0.96 (0.61, 1.53) 47/84 49/81 0.92 (0.71, 1.20) 12/84 26/81 0.45 (0.24, 0.82)
Trochu et al. (2004) (37)* 12 38/102 42/100 0.89 (0.63, 1.25) 58/95 71/100 0.86 (0.70, 1.05) 47/95 64/100 0.77 (0.60, 0.99)
Subtotal 0.81 (0.65, 1.01) 0.81 (0.72, 0.91) 0.72 (0.59, 0.87)
Summary for specialized
multidisciplinary team follow-
up (clinic or non-clinic
settings)
Subtotal 0.75 (0.59, 0.96) 0.81 (0.71, 0.92) 0.74 (0.63, 0.87)
Telephone follow-up and
attendance with primary care
physician if deteriorates
Naylor et al. (1994) (28)* 3 NR NR NR 16/72 23/70 0.68 (0.39, 1.17) NR NR NR
Weinberger et al. (1996) (10)* 6 NR NR NR 130/249 106/255 1.26 (1.04, 1.52) NR NR NR
PHARM (1999) (29) 6 3/90 5/91 0.61 (0.15, 2.46) NR NR NR NR NR NR
Rainville et al. (1999) (30) 12 1/17 4/17 0.25 (0.03, 2.01) NR NR NR 4/17 10/17 0.40 (0.16, 1.03)
Pugh et al. (2001) (26) 6 NR NR NR NR NR NR 9/25 11/30 0.98 (0.49, 1.98)
Jerant et al. (2001) (15)* 6 2/25 0/12 2.50 (0.13, 48.36) 8/25 7/12 0.55 (0.26, 1.16) 2/25 4/12 0.24 (0.05, 1.13)
de Lusignan et al. (2001) (31) 12 2/10 3/10 0.67 (0.14, 3.17) NR NR NR NR NR NR
Riegel et al. (2002) (33)* 6 16/130 32/228 0.88 (0.50, 1.54) 56/130 114/228 0.86 (0.68, 1.09) 23/130 63/228 0.64 (0.42, 0.98)
Laramee et al. (2003) (35)* 3 13/141 15/146 0.90 (0.44, 1.82) 49/134 46/130 1.03 (0.75, 1.43) 18/134 21/130 0.83 (0.46, 1.49)
Tsuyuki et al. (2004) (36)* 6 16/140 12/136 1.30 (0.64, 2.64) 59/140 51/136 1.12 (0.84, 1.50) 37/140 38/136 0.95 (0.64, 1.39)
Subtotal 0.91 (0.67, 1.29) 0.98 (0.80, 1.20) 0.75 (0.57, 0.99)
Continued on next page
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August 18, 2004:810–9 Multidisciplinary Management of HFultidisciplinary team (RR 0.68, 95% CI 0.56 to 0.83),
elephone follow-up (RR 0.77, 95% CI 0.63 to 0.95), or
nhanced patient education and self-care activities (RR
.68, 95% CI 0.54 to 0.87).
OTAL HF HOSPITALIZATIONS. The frequency of multiple
e-admissions for HF was particularly affected by the
ultidisciplinary strategies, such that total HF hospitaliza-
ions were markedly reduced (20 trials, RR 0.57, 95% CI
.49 to 0.67). There were no appreciable differences be-
ween types of interventions: RR 0.67 (95% CI 0.53 to 0.83)
or multidisciplinary HF clinics, RR 0.47 (95% CI 0.36 to
.61) for specialized follow-up by multidisciplinary team,
R 0.65 (95% CI 0.49 to 0.85) for telephone follow-up, and
R 0.60 (95% CI 0.41 to 0.88) for enhanced patient
ducation and self-care activities.
THER END POINTS. Six (9,16,18,20,29,37) of the 10 trials
10,13,14,27) that assessed the use of proven efficacious
edications demonstrated significantly higher prescribing
ates (or dosing) in those patients randomized to the
ultidisciplinary strategies. Five (18,23,24,31,35) of the six
36) trials that examined patient compliance reported sig-
ificantly higher adherence rates to medications and dietary/
uid restrictions in patients exposed to the multidisciplinary
nterventions. Nine (9,14,18,19,23,25,32,33,37) of the 18
rials (10,12,16,17,28,30,31) that assessed patient quality of
ife or functional status demonstrated significantly better
utcomes in the intervention arms (another two trials
13,26] reported a nonsignificant trend toward better quality
f life scores). Finally, although none of these trials included
ormal cost-effectiveness analyses, 15 (9,11–13,15,16,
9,22,23,25,28,33,34,36,37) of the 18 trials describing the
osts of the intervention reported that it was cost-saving
the other three trials [18,26,35] reported their interven-
ions to be cost-neutral).
ENSITIVITY ANALYSES. Analyses did not reveal any signif-
cant effects of year of publication, duration of intervention,
adad score, sample size, or length of follow-up on our
esults.
ISCUSSION
n summary, pooling the data from the 29 randomized trials
f multidisciplinary management strategies for patients with
F reveals that these programs are associated with a 27%
eduction in HF hospitalization rates (NNT  11) and a
3% reduction in total number of HF hospitalizations.
hose strategies that incorporate specialized follow-up by a
ultidisciplinary team or in a multidisciplinary HF clinic
lso reduce all-cause mortality by approximately one-quarter
NNT  17) and all-cause hospitalizations by one-fifth
NNT  10). The beneficial effects of these multidisci-
linary strategies compare favorably with established drug
reatments for HF (for example, angiotensin-converting
nzyme inhibitors reduce mortality by 20% [NNT  19]
nd HF hospitalization rates by 33% [NNT 16] in similarpatient populations) (39) and suggest that the currentT * w
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Multidisciplinary Management of HF August 18, 2004:810–9nthusiasm for these programs is not misplaced. Further,
lthough none of these trials incorporated formal cost-
ffectiveness analyses, 15 of the 18 trials reported that their
ultidisciplinary interventions were cost-saving (the other
hree trials reported cost neutrality), and recent analyses in
he U.K. and U.S. have shown that when applied on a
ational basis, multidisciplinary management strategies have
he potential to deliver substantial cost savings (6,40).
In our earlier systematic review (5), we were unable to
raw any conclusions about which elements of these mul-
idisciplinary strategies were most efficacious in patients
ith HF. Incorporating the trials published over the past
ve years, enhanced patient self-care, follow-up monitoring
y specially trained staff, and access to specialized HF clinics
ppear to be the most efficacious approaches. Although
elephone follow-up programs that advise deteriorating
atients to see their regular physician do reduce HF hospi-
alizations, they have no impact on mortality or all-cause
ospitalizations. Of note, while this conclusion is based on
he 10 trials (1,897 patients) of telephone support programs
ublished thus far, it is also consistent with the preliminary
eport from the DIAL Trial Investigators (1,518 patients
rom 51 centers) presented at the 2002 American Heart
ssociation Meeting (41).
Whereas the specific elements to be included in any
ultidisciplinary disease management program should take
nto account those features unique to each health region
including prevalence, local barriers to optimal care, and
ocal resources), we believe that three elements are crucial to
he success of these programs. First, specially trained HF
urses should be key components of any intervention.
econd, efforts should be made to educate patients and their
aregivers about HF, precipitating factors, and the need for
ompliance with medication and dietary advice (particularly
ecause most HF re-admissions are caused by factors that
atients can be taught to recognize and avoid) (42). Finally,
here must be ready access to clinicians trained in HF.
There are a few important caveats with this systematic
eview. First and foremost, all but two of these trials tested
rograms in high-risk HF patients (i.e., those who had been
ecently discharged from hospital), and all programs were
dministered by specially trained staff from academic health
enters in urban areas. Whether the same benefits could be
btained in lower risk patients or if the programs were
elivered by staff without special training is uncertain, but
eems unlikely. Second, these trials were relatively short in
uration, raising questions about their long-term effective-
ess. However, the median survival of patients with HF
fter hospital discharge is only 18 to 24 months (3,43).
hus, interventions that demonstrate substantial benefits so
uickly in HF are particularly welcome. In addition, pre-
iminary evidence suggests that the benefits from at least one
f these programs were maintained over a further five years
f follow-up (44). Although concerns may be raised that
ttendance at a specialized HF clinic may improve the
rovision of effective HF therapies at the expense of othereeded medications (45), we chose all-cause mortality as our
rimary outcome and all-cause hospitalizations as one of our
econdary outcomes for this very reason. Further, our
valuation of the incremental benefits of the various com-
onents of each intervention is hampered by the lack of
irect comparisons. For example, a recent trial reported that
aily nurse-supervised telemonitoring of HF patients was
ore efficacious and less costly than home visits by nurses
ho were not specially trained in HF (46). However,
djusted indirect comparisons such as those we present in
his systematic review have been shown to provide reason-
ble estimates of the relative efficacy of different interven-
ions when the control arms are similar (8). Finally, few of
hese trials reported on prescribing rates for angiotensin-
onverting enzyme inhibitors or beta-blockers, preventing
s from examining whether the benefits of these programs
re merely attributable to improved prescribing patterns or
atient compliance, or whether the benefits are additive to
ptimal medical therapy.
In conclusion, a wide variety of multidisciplinary strate-
ies to manage patients with HF reduce HF hospitaliza-
ions. Strategies that incorporate follow-up monitoring by
pecially trained staff and/or access to specialized HF clinics
lso reduce mortality and all-cause hospitalizations. Indeed,
he benefits and cost-effectiveness of these programs com-
are favorably with established drug treatments for HF. The
uestion is no longer whether these programs work, but
ather which of these programs work best. Our systematic
eview suggests that patient education to enhance self-care,
ollow-up monitoring by specially trained staff, and access to
pecialized HF clinics are the most efficacious approaches.
hese conclusions are based on adjusted indirect compari-
ons, and direct comparisons of different types of interven-
ions (and/or different intensities) in head-to-head trials
hould be the next frontier for research in this field. The
hallenge for policymakers is to incorporate this evidence
nto future health care planning to deal with the current
pidemic of HF patients being discharged from acute care
nstitutions throughout North America.
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